Literature DB >> 24521540

Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.

Karen E Stewart1, Deborah L Haller, Carol Sargeant, James L Levenson, Puneet Puri, Arun J Sanyal.   

Abstract

BACKGROUND & AIMS: Weight management is a cornerstone of treatment for overweight/obese persons with non-alcoholic fatty liver disease (NAFLD). This exploratory study sought to: (i) evaluate readiness to change weight-related behaviours; (ii) assess psychosocial characteristics that may interfere with weight loss; and (iii) evaluate how baseline psychosocial features associate with 6-month change in weight in persons with NAFLD receiving standard medical care. The purpose of this investigation was to develop hypotheses regarding relationships between psychosocial factors and weight for use in future fully powered studies and clinical interventions
METHODS: Fifty-eight overweight/obese participants with NAFLD completed baseline measures of personality, psychiatric symptoms and readiness for behaviour change and were followed up for 6 months in standard care.
RESULTS: One-third of participants (31.0%) were not interested in making weight-related behaviour changes; 58.6% were considering making a change, and 10.4% of individuals were actively working on or preparing to change. Six-month change in weight was non-significant and was not associated with baseline readiness for change. Depression, low conscientiousness and high neuroticism were associated with higher weight at 6-month follow-up with small to large effect sizes.
CONCLUSIONS: Although participants received nutritional education and guidance, very few individuals presented in the active stage of change. Although readiness for change did not predict subsequent change in weight, personality factors and psychiatric symptoms were associated with weight outcomes. Integrated multidisciplinary approaches that address psychiatric needs and provide behavioural support for weight loss may help patients with NAFLD implement sustained lifestyle changes.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NAFLD; obesity; personality; psychiatric symptoms; readiness to change

Mesh:

Year:  2014        PMID: 24521540      PMCID: PMC4266620          DOI: 10.1111/liv.12483

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  28 in total

1.  The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Anna Mae Diehl; Elizabeth M Brunt; Kenneth Cusi; Michael Charlton; Arun J Sanyal
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

Review 2.  A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment.

Authors:  E Smith; P Hay; L Campbell; J N Trollor
Journal:  Obes Rev       Date:  2011-09       Impact factor: 9.213

3.  Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.

Authors:  Brent A Neuschwander-Tetri; Jeanne M Clark; Nathan M Bass; Mark L Van Natta; Aynur Unalp-Arida; James Tonascia; Claudia O Zein; Elizabeth M Brunt; David E Kleiner; Arthur J McCullough; Arun J Sanyal; Anna Mae Diehl; Joel E Lavine; Naga Chalasani; Kris V Kowdley
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 4.  The psychology of patient compliance: a focused review of the literature.

Authors:  Tracie M Umaki; Michael R Umaki; Charles M Cobb
Journal:  J Periodontol       Date:  2011-08-05       Impact factor: 6.993

Review 5.  Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review.

Authors:  J C M Barte; N C W ter Bogt; R P Bogers; P J Teixeira; B Blissmer; T A Mori; W J E Bemelmans
Journal:  Obes Rev       Date:  2010-12       Impact factor: 9.213

6.  Personality and obesity across the adult life span.

Authors:  Angelina R Sutin; Luigi Ferrucci; Alan B Zonderman; Antonio Terracciano
Journal:  J Pers Soc Psychol       Date:  2011-09

Review 7.  Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials.

Authors:  M J Armstrong; T A Mottershead; P E Ronksley; R J Sigal; T S Campbell; B R Hemmelgarn
Journal:  Obes Rev       Date:  2011-06-21       Impact factor: 9.213

8.  Associations of mood and anxiety disorders with obesity: comparisons by ethnicity.

Authors:  Jamie S Bodenlos; Stephenie C Lemon; Kristin L Schneider; Madeline A August; Sherry L Pagoto
Journal:  J Psychosom Res       Date:  2011-04-22       Impact factor: 3.006

9.  Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C.

Authors:  Ali A Weinstein; Jillian Kallman Price; Maria Stepanova; Laura W Poms; Yun Fang; Juhi Moon; Fatema Nader; Zobair M Younossi
Journal:  Psychosomatics       Date:  2011 Mar-Apr       Impact factor: 2.386

10.  Missed by an inch or a mile? Predicting the size of intention-behaviour gap from measures of executive control.

Authors:  Julia L Allan; Marie Johnston; Neil Campbell
Journal:  Psychol Health       Date:  2011-05-24
View more
  16 in total

Review 1.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  Current and future pharmacologic treatment of nonalcoholic steatohepatitis.

Authors:  Bubu A Banini; Arun J Sanyal
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

4.  Office-Based Weight Loss Counseling Is Ineffective in Liver Transplant Recipients.

Authors:  Samarth S Patel; Mohammad B Siddiqui; Anchalia Chadrakumaran; Masoud Faridnia; Fei-Pi Lin; Jose Hernandez Roman; Salvatore Carbone; John Laurenzo; Joseph Clinton; Danielle Kirkman; Susan Wolver; Francesco Celi; Chandra Bhati; Mohammad S Siddiqui
Journal:  Dig Dis Sci       Date:  2019-08-22       Impact factor: 3.199

Review 5.  Behavioral health disorders related to nonalcoholic steatohepatitis.

Authors:  Aadi Sharma; Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-07-16

Review 6.  Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease.

Authors:  Rachel Holmes; Anahli Patel; Archita P Desai
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-05-23

7.  Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.

Authors:  Preya Janubhai Patel; Kelly Lee Hayward; Rathiga Rudra; Leigh Ula Horsfall; Fabrina Hossain; Suzanne Williams; Tracey Johnson; Nigel Neil Brown; Nivene Saad; Andrew Donald Clouston; Katherine Anne Stuart; Patricia Casarolli Valery; Katharine Margaret Irvine; Anthony William Russell; Elizabeth Ellen Powell
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 8.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022

9.  Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.

Authors:  Bubu A Banini; Arun J Sanyal
Journal:  Clin Med Insights Ther       Date:  2016-12-18

Review 10.  A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD.

Authors:  Newaz Hossain; Pushpjeet Kanwar; Smruti R Mohanty
Journal:  Gastroenterol Res Pract       Date:  2016-02-23       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.